COMPOSITION AND PRODUCTION OF SPINACH EXTRACT WITH BETA-ECDYSONE

Abstract

The invention relates to a spinach extract with a high content of ß-ecdysone and polyphenols, as well as to a method for producing such an extract. The extracts are characterised inter alia by their protein-increasing effect on muscle cells and by a high anti-oxidative potential.

Description

Composition and production of spinach extract with β-ecdysone Description The present invention relates to the field of extracts, more precisely to extracts from spinach. Spinach and spinach extracts are of great interest due to their beneficial properties, not only in the food industry but also in cosmetics. Food supplements, animal feed or pharmaceuticals. Therefore, there is a constant need to further improve existing extracts. This problem is solved by an extract according to claim 1. Accordingly, a spinach extract is presented, containing >0.002 to <15% β-ecdysone and >0.01% to <50% polyphenols, each as a mass fraction in the dry product. The term "spinach extract" refers in particular to a mixture of substances and / or a Composition understood, which consists of spinach (Spinacia oleracea; also called common spinach, vegetable spinach or garden spinach) or blanching water to its Preservation is achieved. Depending on the application, this involves extraction and partial or complete evaporation of the extraction solvents (e.g., water or...). An extraction solution is obtained using ethanol, which can be further dried by various methods. However, for the purposes of the present invention, the term "extract" also includes extracts from plant drugs, which are produced, inter alia, by maceration or percolation with water or ethanol. The term "β-ecdysone" refers to 20-hydroxyecdysone with the following structure: This substance is also known in the literature under the names β-Ecdysone, 2β,3β,14a,20β,22,25-Hexahydroxy-7-cholesten-6-one, Ecdysterone, Insect moulting hormone, Polypodine A. For the purposes of the present inventions, polyphenols are understood to be, in particular, aromatic compounds containing two or more hydroxyl groups directly bonded to an aromatic ring. Most of these compounds belong to the group of secondary plant metabolites. Surprisingly, this extract has been shown to have a predominantly very high antioxidant potential. In most applications of the present invention, one or more of the following advantages can be observed or achieved: • An extract according to the invention consisting of highly diluted Solutions, emulsions or suspensions (e.g. from side streams of the (Food production). • The extract is in a stable form and has only a slight coloration, which is why it is also well suited for use in other applications. • It is a standardized extract that has a defined β-ecdysone content and a beneficial flavonoid composition, • The extract is soluble in both polar solvents such as water and nonpolar solvents such as vegetable oil. • The extract has a low content of the substances nitrate / nitrite and oxalic acid. According to a preferred embodiment of the invention, the β-ecdysone content is >0.1% to <15%, more preferably >0.1% to <10%, still more preferably >2% to <8%, and most preferably >5% to <7%. This has proven particularly advantageous in most applications. According to a preferred embodiment of the invention, the content of Polyphenols between >2 and <50, preferably >10% to <40, and most preferably >25 to <30. According to a preferred embodiment of the invention, the polyphenols comprise flavonoids. This includes, in particular, compounds containing two aromatic rings connected by a tetrahydropyran ring. Preferably the proportion of flavonoids in the extract is between >10% and <38%, more preferably >14% and <32%, and most preferably >25% and <30%. The flavonoids preferably comprise one or more compounds selected from glucuronides, di- or triglycosides of methylated and / or methylenedioxyderivatized 6-oxo-flavonols. The flavonoids preferably comprise one or more of the following: Connections: 5,3',4'-Trihydroxy-3-methoxy-6,7-methylenedioxyflavone 4'-glucuronide with the following structure: Jaceidin 4'-glucuronide = (3S,6S)-6-[4-(5,7-dihydroxy-3,6-dimethoxy-4-oxochromen-2-yl)-2-methoxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid with the following structure: Spinacetin 3-gentiobiosid = 5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-6-methoxy-3- [(2R,5S)-3,4,5-trihydroxy-6-[[(2R,4S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2- yl]oxymethyl]oxan-2-yl]oxychromen-4-on mit folgender Struktur: Isorhamnetin 3-sophoroside-7-glucosid = 3-[(2S,5S)-4,5-dihydroxy-6-(hydroxymethyl)-3- [(2S,3R,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2- (4-hydroxy-3-methoxyphenyl)-7-[(2S,4S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2- yl]oxychromen-4-on mit folgender Struktur: Spinatosid = 3,4',5,7-Tetrahydroxy-3',6-dimethoxyflavon mit folgender Struktur The extract preferably comprises spinatoside and 5,3',4'-trihydroxy-3-methoxy-6:7-methylenedioxy-flavone-4'-O-glucuronide. This has proven effective in many applications, as the antioxidant potential is often surprisingly high. It is particularly preferred that the ratio of spinatoside to 5,3',4'-trihydroxy-3-methoxy-6:7-methylenedioxy-flavone-4'-O-glucuronide is between >1:0.1 and <1:20 (Wt:Wt). This has also proven effective in many applications, as it often and surprisingly further enhances the antioxidant potential. Particularly preferably the ratio of spinatoside to 5,3',4'-trihydroxy-3-methoxy-6:7-methylenedioxy-flavone-4'-O-glucuronide is between >1:0.5 and <1:8, even more preferably >1:2 and <1:5. Preferably, the combined nitrate / nitrite content in the extract is <500 ppm. This has proven advantageous in many applications of the present invention. Preferably, the combined proportion of nitrate / nitrite in the extract is <400 ppm, even more preferably <300 ppm. Preferably, the oxalate content in the extract is <500 ppm. This has also proven to be advantageous. Preferably, the absorption of a 0.5 wt% solution of the extract in distilled water at 507 nm is <0.5. This has proven advantageous in many applications of the present invention, as it allows the extract to be used in many sensitive applications due to its relative color neutrality. Preferably, the absorption of a 0.5 wt% solution of the extract in distilled water at 580 nm is <0.35. This has also proven advantageous in many applications of the present invention, as the extract, due to its relative color neutrality, can be used in many sensitive applications. The present invention also relates to a medicinal product containing the extract according to the invention and / or to the use of the extract according to the invention as a medicinal product. Surprisingly, it has turned out that the inventive extract is suitable for the It can be used to treat muscle atrophy, muscle hypotonia, and sarcopenia. The present invention therefore also relates to a medicament for the treatment of muscle atrophy, muscle hypotonia and / or sarcopenia, comprising the extract according to the invention. Furthermore, the present invention relates to the use of a medicament containing the extract according to the invention for the treatment of muscle atrophy, Muscle hypotonia and / or sarcopenia. Furthermore, the present invention relates to a method for treating muscle atrophy, muscle hypotonia and / or sarcopenia comprising the step - Administering a sufficient quantity of a medicinal product containing the extract according to the invention to a patient. The medicinal products within the meaning of the present invention are preferably ready-to-use pharmaceutical preparations, preferably in the following forms: solid galenic forms (such as tablets (coated and uncoated, modified-release and uncoated), coated tablets (coated and uncoated, modified-release and uncoated), capsules (soft or hard gelatin capsules, modified-release and uncoated), granules (modified-release and uncoated), powders (modified-release and uncoated), suppositories (coated and uncoated, modified-release and uncoated), lozenges, chewing gum), as well as liquid forms (such as solutions, suspensions, emulsions, syrups (colloquially cough syrup), mouthwashes, gargles, throat sprays or nasal sprays, nasal drops, nasal irrigation solutions, nasal powders, nasal ointments or ear drops, ear sprays, ear irrigation solutions, ear powders, ear tampons), and semi-solid forms (such as hydrophobic ointments, including, for example,Hydrocarbon gels, lipogels, silicone gels, oleogels, and water-absorbing ointments, including, for example, absorption bases, hydrophilic ointments, hydrophilic gels (hydrogels) or pastes, as well as inhalants (such as pressurized metered-dose inhalers, powder inhalers, inhalers with atomizers, inhalation concentrates for preparing inhalations), and medicated patches or other therapeutic systems. The pharmaceutical preparations according to the invention may contain (further) pharmaceutical excipients and / or additives such as are commonly used in such preparations, e.g. active ingredients as well as fillers (e.g. cellulose, calcium carbonate), flow agents and anti-caking agents (e.g. talc, magnesium stearate), coatings (e.g. polyvinyl acetate phthalate, hydroxypropyl methylcellulose phthalate), disintegrants (e.g. starch, cross-linked polyvinylpyrrolidone), plasticizers (e.g. triethyl citrate, dibutyl phthalate) Substances for granulation (lactose, gelatin), retardation (e.g., poly(meth)acrylic acid-methyl / ethyl / 2-trimethylaminoethyl ester copolymers in dispersion, vinyl acetate / crotonic acid copolymers), compaction (e.g., microcrystalline cellulose, lactose), solvents, suspending or dispersing agents (e.g., water, ethanol), emulsifiers (e.g., cetyl alcohol, lecithin), substances for modifying theological properties (silicon dioxide, sodium alginate), substances for microbial stabilization (e.g., benzalkonium chloride, potassium sorbate), preservatives and antioxidants (e.g., DL-alpha-tocopherol, ascorbic acid), substances for modifying pH (lactic acid, citric acid), propellant or inert gases (e.g., fluorinated chlorinated hydrocarbons, carbon dioxide), dyes (iron oxides, titanium dioxide), ointment bases (e.g., paraffins, beeswax), among other things as described in specialist literature (e.g. Schmidt, Christin. Active ingredients and excipients for formulation, extemporaneous preparation and large-scale production.1999; Wissenschaftliche Verlagsgesellschaft mbH Stuttgart or Bauer, Frömming Führer. Textbook of Pharmaceutical Technology. 8th edition, 2006. Wissenschaftliche Verlagsgesellschaft mbH Stuttgart). The quantities to be used can be easily determined by a person skilled in the art through simple trial and error, depending on the type of product. The present invention also relates to an aroma mixture comprising the extract according to the invention. The present invention further relates to finished products comprising the extract according to the invention. These can be food and / or food supplements and / or corresponding products for animal nutrition and / or animal health. Insofar as the finished products are food items to which the extract is directly added, these include, for example, baked goods such as bread. Dry biscuits, cakes, other pastries, confectionery (e.g. chocolates, Chocolate bar products, other bar products, fruit gums, hard and Soft caramels, chewing gum), alcoholic or non-alcoholic beverages (e.g., coffee, tea, iced tea, wine, wine-based drinks, beer, beer-based drinks, liqueurs, schnapps, brandies, (carbonated) fruit-based soft drinks, (carbonated) isotonic drinks, (carbonated) soft drinks, nectars, spritzers, fruit and vegetable juices, fruit or vegetable juice preparations, instant drinks (e.g., instant cocoa drinks, instant tea drinks, instant coffee drinks, instant fruit drinks), meat products (e.g., ham, fresh or raw sausage preparations, seasoned or marinated fresh or cured meat products), eggs or egg products) (Dried egg, egg white, egg yolk), cereal products (for example, breakfast cereals, Muesli bars, pre-cooked ready-made rice products), dairy products (e.g., milk drinks, buttermilk drinks, ice cream, yogurt, kefir, cream cheese, soft cheese, hard cheese, Dried milk powder, whey, whey drinks, butter, buttermilk, partially or fully hydrolyzed milk protein products, products made from soy protein or other Soybean fractions (for example, soy milk and products made from it, Fruit drinks containing soy protein, preparations containing soy lecithin, fermented products such as tofu or tempeh or products made from them), products from other plant protein sources, for example oat protein drinks, fruit preparations (e.g. jams, fruit ice cream, fruit sauces, fruit fillings), vegetable preparations (e.g. ketchup, sauces, dried vegetables, frozen vegetables, precooked vegetables, preserves) Vegetables), snack foods (e.g., baked or fried potato chips or potato dough products, extrudates based on corn or peanuts), fat- and oil-based products or emulsions thereof (e.g., mayonnaise, remoulade, dressings), other ready meals and soups (e.g., dry soups, instant soups, pre-cooked soups), spices, seasonings, and especially sprinkle-on seasonings, which are used, for example, in the snack sector. The antioxidant preparations or extracts can be used, in particular, in sports drinks, including those designed to aid in the regeneration of the to serve athletes after intensive sporting activity or to increase performance. The extract is usually added in amounts of about 0.1 to 5, preferably about 0.5 to 3 and in particular about 1 to 2 wt. 1. Capsules If the products are dietary supplements, they are generally used without further additives, and pure packaging materials should be avoided. Macro- or microcapsules are a preferred application form. Macrocapsules preferably consist of gelatin. These generally exhibit The particle diameter ranges from 0.5 to 1.5 cm. Alternatively, they are spray-dried products containing polysaccharides or dextrins as a base. The terms "microcapsule" or "nanocapsule" are understood by those skilled in the art to mean spherical aggregates with a diameter in the range of approximately 0.0001 to approximately 5 mm, and preferably 0.005 to 0.5 mm, containing at least one solid or liquid core enclosed by at least one continuous shell. More precisely, these are finely dispersed liquid or solid phases coated with film-forming polymers, the production of which involves the polymers being deposited on the material to be coated after emulsification and coacervation or interfacial polymerization. In another process, molten waxes are incorporated into a matrix. ("microsponge"), which, as microparticles, can additionally be coated with film-forming polymers. A third method involves coating particles alternately with polyelectrolytes of different charges ("layer-by-layer" process). The microscopically small capsules can be dried like powder. In addition to mononuclear microcapsules, multinuclear aggregates, also called microspheres, are known, which contain two or more nuclei distributed within the continuous coating material. Mononuclear or multinuclear microcapsules can Furthermore, it may be enclosed by an additional second, third, etc., layer. The layer can consist of natural, semi-synthetic, or synthetic materials. Examples of natural layer materials include gum arabic, agar-agar, agarose, maltodextrins, alginic acid or its salts, e.g., sodium or calcium alginate, fats and fatty acids, cetyl alcohol, collagen, chitosan, lecithins, gelatin, albumin, shellac, polysaccharides such as starch or dextran, polypeptides, protein hydrolysates, sucrose, and waxes. Semi-synthetic coating materials include chemically modified celluloses, especially cellulose esters and ethers, e.g., cellulose acetate, ethylcellulose, Hydroxypropylcellulose, hydroxypropylmethylcellulose, and carboxymethylcellulose, as well as starch derivatives, especially starch ethers and esters. Synthetic coating materials include polymers such as polyacrylates, polyamides, and polyvinyl alcohol. Polyvinylpyrrolidone. Examples of state-of-the-art microcapsules are the following commercial products (the shell material is given in parentheses): Hallcrest Microcapsules (gelatin, gum arabic), Coletica Thalaspheres (maritime collagen), Lipotec Millicapsules (alginic acid, agar agar), Induchem Unispheres (lactose, microcrystalline cellulose, hydroxypropylmethylcellulose); Unicerin C30 (lactose, microcrystalline cellulose, hydroxypropylmethylcellulose), Kobo Glycospheres (modified starch, fatty acid esters, phospholipids), Softspheres (modified agar-agar) and Kuhs Probiol Nanospheres (phospholipids) as well as Primaspheres and Primasponges (chitosan, alginates) and Primasys (phospholipids). 2. Chewing gum Another way to administer the extracts is in the form of chewing gum. These products typically contain a water-insoluble and a water-soluble extract. Component. The water-insoluble base, also known as the "gum base", comprises typically natural or synthetic elastomers, resins, fats and oils, plasticizers, Fillers, colorants, and optionally waxes. The base typically comprises 5 to 95 wt., preferably 10 to 50 wt., and particularly 20 to 35 wt. in the total composition. In a typical embodiment of the invention, the base consists of 20 to 60 wt. synthetic elastomers, 0 to 30 wt. natural elastomers, 5 to 55 wt. plasticizers, 4 to 35 wt. fillers, and, in subordinate quantities, additives such as colorants, antioxidants, and the like, provided that they are only soluble in water to a small extent. Suitable synthetic elastomers include, for example, polyisobutylenes with average molecular weights (according to GPC) of 10,000 to 100,000 and Preferably 50,000 to 80,000, isobutylene-isoprene copolymers ("butyl elastomers"), styrene-butadiene copolymers (styrene-butadiene ratio e.g. 1:3 to 3:1), polyvinyl acetates with average molecular weights (according to GPC) of 2,000 to 90,000 and preferably 10,000 to 65,000, polyisoprenes, polyethylene, vinyl acetate-vinyl laurate copolymers and mixtures thereof. Examples of suitable natural elastomers are rubbers such as smoked or liquid latex or guayule, as well as natural rubbers such as jelutong, lechi caspi, perillo, sorba, massaranduba balata, massaranduba chocolate, nispero, rosindinba, chicle, gutta hang lkang and mixtures thereof. The selection of synthetic and natural elastomers and their mixing ratios depends primarily on whether the chewing gum is intended to produce bubbles ("bubble gums") or not. Preferably, elastomer mixtures containing jelutong, chicle, sorba, and massaranduba are used. In most cases, elastomers prove to be too hard or insufficiently deformable during processing, making the use of special plasticizers advantageous. These plasticizers, of course, must also meet all requirements for approval as food additives. In this respect, esters of resin acids are particularly suitable, for example, esters of lower aliphatic alcohols or polyols with fully or partially hydrogenated, monomeric or oligomeric resin acids. Methyl, glycerol, or pentaerythritol esters, as well as mixtures thereof, are used for this purpose. Alternatively, terpene resins derived from alpha-pinene, beta-pinene, delta-limonene, or mixtures thereof are also suitable. Fillers or texturizing agents include magnesium or calcium carbonate, ground pumice, silicates (especially magnesium or aluminum silicates), clays, aluminum oxides, talc, titanium dioxide, mono-, di-, and tricalcium phosphate, and cellulose polymers. Suitable emulsifiers are tallow, hydrogenated tallow, hydrogenated or partially hydrogenated vegetable oils, cocoa butter, partial glycerides, lecithin, triacetin and saturated or unsaturated fatty acids with 6 to 22 and preferably 12 to 18 carbon atoms, as well as mixtures thereof. Examples of dyes and whitening agents used include those for coloring Food-approved FD and C-types, plant and fruit extracts, as well as Titanium dioxide is a possibility. The base masses may contain waxes or be wax-free; examples of wax-free compositions can be found, among others, in patent specification US 5,286,500, the contents of which are hereby expressly incorporated by reference. In addition to the water-insoluble gum base, chewing gum preparations regularly contain a water-soluble component, which includes, for example, softeners, sweeteners, fillers, flavorings, flavor enhancers, and emulsifiers. Dyes, acidulants, antioxidants, and the like are formed, provided that the components possess at least sufficient water solubility. Depending on the water solubility of the specific components, individual components can therefore belong to both the water-insoluble and the water-soluble phase. However, it is also possible to form combinations, for example, of a water-soluble and a Water-insoluble emulsifiers are used, with the individual components then existing in different phases. Typically, the water-insoluble fraction makes up 5 to 95% and preferably 20 to 80% by weight of the preparation. Water-soluble softeners or plasticizers are added to the chewing gum compositions to improve chewability and texture and are found in the Mixtures are typically present in amounts of 0.5 to 15 wt. Typical examples are glycerin, lecithin, and aqueous solutions of sorbitol, hydrogenated starch hydrolysates, or corn syrup. Suitable sweeteners include both sugar-containing and sugar-free compounds, used in amounts of 5 to 95%, preferably 20 to 80%, and particularly 30 to 60% by weight, based on the chewing gum composition. Typical saccharide sweeteners are sucrose, dextrose, maltose, dextrin, dried invert sugar, fructose, and levulose. Galactose, corn syrup, and mixtures thereof. Suitable sugar substitutes include sorbitol, mannitol, xylitol, hydrogenated starch hydrolysates, maltitol, and mixtures thereof. Other additives that may be considered include so-called HIAS ("High Intensity Artificial Sweeteners"), such as sucralose, aspartame, acesulfame salts, alitame, saccharin and saccharin salts, cyclamic acid and its salts, glycyrrhizins, Dihydrochalcones, thaumatin, monellin, and similar substances, alone or in mixtures, are used. Hydrophobic hydrophobic amino acids (HIAS), which are the subject of international patent application WO 2002 091849 AI (Wrigley's), as well as stevia extracts and their active components, especially rebaudioside A, are also particularly effective. The amount used depends primarily on their potency and typically ranges from 0.02 to 8% by weight. Fillers such as polydextrose, raftilose, raftilin, fructooligosaccharides (NutraFlora), palatinose oligosaccharides, guar gum hydrolysate (Sun Fiber) and dextrins are particularly suitable for the production of low-calorie chewing gum. The selection of other flavorings is practically unlimited and uncritical to the essence of the invention. Typically, the total proportion of all flavorings is between 0.1 and 15%, and preferably between 0.2 and 5% by weight, based on the chewing gum composition. Other suitable flavoring agents include, for example, essential oils, synthetic flavorings and the like, such as anise oil, star anise oil, caraway oil, eucalyptus oil, Fennel oil, lemon oil, wintergreen oil, clove oil, and the like, as they are also used, for example, in oral and dental care products. The chewing gum may also contain excipients and additives suitable for dental care, specifically for combating plaque and gingivitis, such as chlorhexidine, CPC, or trichlosan. Furthermore, it may contain pH regulators (e.g., buffers or urea), anti-cariogenic agents (e.g., phosphates or fluorides), and biogenic agents (antibodies, enzymes, caffeine, plant extracts), provided these substances are approved for use in food and do not interact undesirably with each other. Interaction occurs. The preferred oral preparations may also include chewing gum. These products typically contain a water-insoluble and a water-soluble component. Component. The water-insoluble base, also known as the "gum base", comprises Typically natural or synthetic elastomers, resins, fats and oils, plasticizers, fillers, dyes, and possibly waxes. The proportion of the base in the The total composition typically comprises 5 to 95 wt., preferably 10 to 50 wt., and particularly 20 to 35 wt. parts by weight. In a typical embodiment of the invention, the base consists of 20 to 60 wt. synthetic elastomers, 0 to 30 wt. natural elastomers, 5 to 55 wt. plasticizers, 4 to 35 wt. fillers, and, in subordinate quantities, additives such as colorants, antioxidants, and the like, provided that they are only soluble in water to a small extent. Suitable synthetic elastomers include, for example, polyisobutylenes with average molecular weights (according to GPC) of 10,000 to 100,000 and preferably 50,000 to 80,000, isobutylene-isoprene copolymers ("butyl elastomers"), styrene-butadiene copolymers (styrene:butadiene ratio e.g. 1:3 to 3:1), polyvinyl acetates with average molecular weights (according to GPC) of 2,000 to 90,000 and preferably 10,000 to 65,000, polyisoprene, polyethylene, vinyl acetate-vinyl laurate copolymers and mixtures thereof. Examples of suitable natural elastomers are: Rubbers such as smoked or liquid latex or guayule, as well as natural rubbers such as jelutong, lechi caspi, perillo, sorba, massaranduba balata, massaranduba chocolate, nispero, rosindinba, chicle, gutta hang lkang, and mixtures thereof. The selection of synthetic and natural elastomers and their mixing ratios depends primarily on whether the chewing gum is intended to produce bubbles ("bubble gums") or not. Elastomer mixtures containing jelutong, chicle, sorba, and massaranduba are preferably used. In most cases, elastomers prove to be too hard or insufficiently deformable during processing, making the use of special plasticizers advantageous. These plasticizers, of course, must also meet all requirements for approval as food additives. In this respect, esters of resin acids are particularly suitable, for example, esters of lower aliphatic alcohols or polyols with fully or partially hydrogenated, monomeric or oligomeric resin acids. Methyl, glycerol, or pentaerythritol esters, as well as mixtures thereof, are particularly suitable for this purpose. Alternatively, terpene resins derived from alpha-pinene, beta-pinene, delta-limonene, or mixtures thereof are also suitable. Fillers or texturizing agents include magnesium or calcium carbonate, ground pumice, silicates (especially magnesium or aluminum silicates), clays, aluminum oxides, talc, titanium dioxide, mono-, di- and tricalcium phosphate, and cellulose polymers. Suitable emulsifiers are tallow, hydrogenated tallow, hydrogenated or partially hydrogenated vegetable oils, cocoa butter, partial glycerides, lecithin, triacetin and saturated or unsaturated fatty acids with 6 to 22 and preferably 12 to 18 carbon atoms, as well as mixtures thereof. Examples of dyes and whitening agents used include those for coloring Food-approved FD and C-types, plant and fruit extracts, as well as Titanium dioxide is a possibility. The base masses may contain waxes or be wax-free; examples of wax-free compositions can be found, among others, in US patent specification 5,286,500, to the contents of which reference is hereby expressly made. In addition to the water-insoluble gum base, chewing gum preparations regularly contain a water-soluble component, which may consist of, for example, plasticizers, sweeteners, fillers, flavorings, flavor enhancers, emulsifiers, and colorings. Acidulants, antioxidants, and the like are formed, provided that the components possess at least sufficient water solubility. The water solubility of the specific representatives can therefore be determined individually. Components may belong to both the water-insoluble and water-soluble phases. However, it is also possible to use combinations, for example, of a water-soluble and a water-insoluble emulsifier, in which case the individual components are located in different phases. Typically, the water-insoluble fraction makes up 5 to 95% and preferably 20 to 80% by weight of the preparation. Water-soluble plasticizers or plasticizers are added to the Chewing gum compounds are added to improve chewability and chewing sensation and are typically present in mixtures in amounts of 0.5 to 15 wt. present. Typical examples are glycerin, lecithin, and aqueous solutions of sorbitol, hydrogenated starch hydrolysates, or corn syrup. Suitable sweeteners include both sugar-containing and sugar-free compounds, used in amounts of 5 to 95%, preferably 20 to 80%, and particularly 30 to 60% by weight, based on the chewing gum composition. Typical saccharide sweeteners are sucrose, dextrose, maltose, dextrin, dried invert sugar, fructose, and levulose. Galactose, corn syrup, and mixtures thereof. Suitable sugar substitutes include sorbitol, mannitol, xylitol, hydrogenated starch hydrolysates, maltitol, and mixtures thereof. Furthermore, so-called HIAS ("High Intensity Artificial") are also used as additives. Sweeteners"), such as sucralose, aspartame, acesulfame salts, alitame, saccharin and saccharin salts, cyclamic acid and its salts, glycyrrhizins, Dihydrochalcones, thaumatin, monellin and the like, alone or in mixtures. Hydrophobic HIAS, the subject of international patent application WO 2002 091849 AI (Wrigley's), as well as stevia extracts and their active components, especially ribeaudioside A, are particularly effective. The amount of these substances used depends primarily on their potency and typically ranges from 0.02 to 8% by weight. Fillers such as polydextrose, raffilose, rafettin, fructooligosaccharides (NutraFlora), palatinose oligosaccharides, guar gum hydrolysate (Sun Fiber), and dextrins are particularly suitable for the production of low-calorie chewing gum. The selection of other flavorings is practically unlimited and uncritical to the essence of the invention. Typically, the total proportion of all flavorings is between 0.1 and 15%, and preferably between 0.2 and 5% by weight, based on the chewing gum composition. Other suitable flavoring substances include, for example, essential oils, synthetic flavorings and the like, such as anise oil, star anise oil, caraway oil, eucalyptus oil, fennel oil, lemon oil, wintergreen oil, clove oil, and the like, as are also used, for example, in oral and dental care products. The chewing gum may also contain excipients and additives suitable for dental care, specifically for combating plaque and gingivitis, such as chlorhexidine, CPC, or trichlosan. Furthermore, it may contain pH regulators (e.g., buffers or urea), anti-cariogenic agents (e.g., phosphates or fluorides), and biogenic agents (antibodies, enzymes, caffeine, plant extracts), provided these substances are approved for use in food and do not interact undesirably with each other. Interactions occur. Cosmetic products Another object of the invention relates to cosmetic products containing an extract according to the invention. The cosmetic products according to the invention may contain further typical excipients and additives, such as mild surfactants, oils, emulsifiers, pearlescent waxes, consistency enhancers, thickeners, superfatting agents, stabilizers, polymers, Silicone compounds, fats, waxes, lecithins, phospholipids, UV sunscreens, humectants, biogenic active ingredients, antioxidants, deodorants, antiperspirants, anti-dandruff agents, film formers, swelling agents, insect repellents, self-tanning agents Tyrosine inhibitors (depigmenting agents), hydrotropes, solubilizers, They contain preservatives, perfume oils, dyes, and the like. Since many The following examples also apply to pharmaceutical preparations containing similar substances. 1. Surfactants The surfactants may be anionic, non-ionic, cationic and / or amphoteric or zwitterionic surfactants, the proportion of which in the products The concentration is typically around 1 to 70, preferably 5 to 50, and particularly 10 to 30 by weight. Typical examples of anionic surfactants are soaps, alkylbenzenesulfonates, alkanesulfonates, olefin sulfonates, alkyl ethersulfonates, glycerol ethersulfonates, α-methyl ester sulfonates, sulfo-fatty acids, alkyl sulfates, alkyl ether sulfates, glycerol ether sulfates, fatty acid ether sulfates, hydroxy mixed ether sulfates, and monoglyceride (ether) sulfates. Fatty acid amide (ether) sulfates, mono- and dialkyl sulfosuccinates, mono- and Dialkylsulfosuccinamates, sulfotriglycerides, amide soaps, ether carboxylic acids and their salts, fatty acid isethionates, fatty acid sarcosinates, fatty acid taurides, N-acylamino acids, such as acyl lactylates, acyltartrates, acyl glutamates and acylaspartates, Alkyl oligoglucoside sulfates, protein fatty acid condensates (especially plant-based products made from wheat), and alkyl (ether) phosphates. Provided the anionic surfactants Containing polyglycol ether chains, these can exhibit a conventional, but preferably a narrow homolog distribution. Typical examples of nonionic surfactants are fatty alcohol polyglycol ethers, alkylphenol polyglycol ethers, fatty acid polyglycol esters, fatty acid amide polyglycol ethers, fatty amine polyglycol ethers, alkoxylated triglycerides, mixed ethers or mixed formals, optionally partially oxidized alk(en)yl oligoglycosides or similar. Glucuronic acid derivatives, fatty acid N-alkylglucamides, protein hydrolysates (especially plant-based products derived from wheat), polyol fatty acid esters, sugar esters, sorbitan esters, polysorbates, and amine oxides. If the nonionic surfactants contain polyglycol ether chains, these can form a conventional, but preferably a restricted, ionic ion. They exhibit homologous distribution. Typical examples of cationic surfactants are quaternary ammonium compounds, such as dimethyldistearylammonium chloride, and esterquats, especially quaternary fatty acid trialkanolamine ester salts. Typical examples of amphoteric or zwitterionic surfactants are alkyl betaines and alkylamidobetaines. Aminopropionates, aminoglycinates, imidazolinium betaines, and sulfobetaines. The surfactants mentioned are all well-known compounds. Typical examples of particularly suitable, mild, i.e., especially skin-friendly, surfactants are fatty alcohol polyglycol ether sulfates, monoglyceride sulfates, and mono- and / or Dialkyl sulfosuccinates, fatty acid isethionates, fatty acid sarcosinates, fatty acid taurides Fatty acid glutamates, α-olefin sulfonates, ether carboxylic acids, alkyl oligoglucosides, fatty acid glucamides, alkylamido betaines, amphoacetals and / or protein fatty acid condensates, the latter preferably based on wheat proteins. 2. Oil body Examples of suitable oil bodies include Guerbet alcohols based on fatty alcohols with 6 to 18, preferably 8 to 10 carbon atoms, esters of linear C6-C22 fatty acids with linear or branched C6-C22 fatty alcohols, or esters of branched C6-C13 carboxylic acids with linear or branched C6-C22 fatty alcohols, such as... Myristyl myristate, myristyl palmitate, myristyl stearate, myristyl isostearate, myristyl oleate, myristyl behenate, myristyl arucate, cetyl myristate, cetyl palmitate, cetyl stearate, cetyl isostearate, cetyl oleate, cetyl behenate, cetyl rucate, stearyl myristate, stearyl palmitate, Stearyl stearate, stearyl isostearate, stearyl oleate, stearyl behenate, stearyl rucate, isostearyl myristate, Isostearyl palmitate, isostearyl stearate, isostearyl isostearate, isostearyl oleate, isostearyl behenate, isostearyl oleate, oleyl myristate, oleyl palmitate, oleyl stearate, oleyl isostearate, oleyl oleate, oleyl behenate, oleyl rucate, behenyl myristate, behenyl palmitate, behenyl stearate, Behenyl isostearate, behenyl oleate, behenyl behenate, behenyl erucate, erucyl myristate, Erucyl palmitate, erucyl stearate, erucyl isostearate, erucyl oleate, erucyl behenate, and erucyl erucate. Also suitable are esters of linear C6-C22 fatty acids with branched alcohols, especially 2-ethylhexanol; esters of C18-C38 alkylhydroxycarboxylic acids with linear or branched C6-C22 fatty alcohols, especially dioctyl malaie; esters of linear and / or branched fatty acids with polyhydric alcohols (such as propylene glycol, dimerdiol, or trimertriol) and / or Guerbet alcohols; triglycerides based on C6-C10 fatty acids; and liquid mono-, di-, or triglyceride mixtures based on C6-C18 fatty acids. Esters of C6-C22 fatty alcohols and / or Guerbet alcohols with aromatic carboxylic acids, especially benzoic acid, esters of C2-C12 dicarboxylic acids with linear or branched alcohols with 1 to 22 carbon atoms or polyols with 2 to 10 carbon atoms and 2 to 6 hydroxyl groups, vegetable oils, branched primary alcohols, substituted Cyclohexanes, linear and branched C6-C22 fatty alcohol carbonates, such as dicaprylyl carbonate (Cetiol CC), Guerbet carbonates based on fatty alcohols with 6 to 18, preferably 8 to 10, carbon atoms, esters of benzoic acid with linear and / or branched C6-C22 alcohols (e.g., Finsolv TN), linear or branched, symmetrical or unsymmetrical dialkyl ethers with 6 to 22 carbon atoms per alkyl group, such as... Dicaprylyl ether (Cetiol<®>OE), ring-opening products of epoxidized fatty acid esters with polyols, silicone oils (cyclomethicone, silicon methicone types, etc.) and / or aliphatic or naphthenic hydrocarbons, such as squalane, squalene, or Consider dialkylcyclohexanes. 3. Emulsifiers Suitable emulsifiers include, for example, nonionic surfactants from at least one of the following groups: • Addition products of 2 to 30 mol of ethylene oxide and / or 0 to 5 mol of propylene oxide to linear fatty alcohols with 8 to 22 carbon atoms, to fatty acids with 12 to 22 carbon atoms, to alkylphenols with 8 to 15 carbon atoms in the alkyl group, and to alkylamines with 8 to 22 carbon atoms in the alkyl group; • Alkyl and / or alkenyl oligoglycosides with 8 to 22 carbon atoms in the alk(en)yl residue and their ethoxylated analogues; • Addition products of 1 to 15 mol of ethylene oxide to castor oil and / or hydrogenated castor oil; • Deposition products of 15 to 60 mol of ethylene oxide on castor oil and / or hydrogenated castor oil; • Partial esters of glycerol and / or sorbitan with unsaturated, linear or saturated, branched fatty acids with 12 to 22 carbon atoms and / or hydroxycarboxylic acids with 3 to 18 carbon atoms and their adducts with 1 to 30 mol of ethylene oxide; • Partial esters of polyglycerol (average degree of intrinsic condensation 2 to 8), Polyethylene glycol (molecular weight 400 to 5000), trimethylolpropane, pentaerythritol, Sugar alcohols (e.g., sorbitol), alkyl glucosides (e.g., methyl glucoside, butyl glucoside, lauryl glucoside), and polyglucosides (e.g., cellulose) with saturated and / or unsaturated, linear or branched fatty acids with 12 to 22 carbon atoms and / or Hydroxycarboxylic acids with 3 to 18 carbon atoms and their adducts with 1 to 30 mol of ethylene oxide; • Mixed esters of pentaerythritol, fatty acids, citric acid and fatty alcohol and / or Mixed esters of fatty acids with 6 to 22 carbon atoms, methyl glucose and polyols, preferably glycerol or polyglycerol. • Mono-, di- and trialkyl phosphates as well as mono-, di- and / or tri-PEG-alkyl phosphates and their salts; • Wool wax alcohols; • Polysiloxane-polyalkyl-polyether copolymers or corresponding derivatives; • Block copolymers e.g. polyethylene glycol-30 dipolyhydroxystearates; • Polymer emulsifiers, e.g., Pemulen types (TR-1, TR-2) from Goodrich or Cosmedia<®>SP by Cognis; • Polyalkylene glycols as well as • Glycerol carbonate. Particularly suitable emulsifiers are explained in more detail below: (i) Alkoxylates. The addition products of ethylene oxide and / or propylene oxide to fatty alcohols, fatty acids, alkylphenols, or castor oil are known, commercially available products. These are homologous mixtures whose average degree of alkoxylation corresponds to the ratio of the amounts of ethylene oxide and / or Propylene oxide and the substrate with which the addition reaction is carried out correspond to C12 / 18 fatty acid mono- and diesters of addition products of ethylene oxide to glycerol are known as refatting agents for cosmetic preparations. (ii) Alkyl and / or alkenyl oligoglycosides. Alkyl and / or alkenyl oligoglycosides, their preparation and their use are known from the prior art. They are prepared in particular by reacting glucose or oligosaccharides with primary Alcohols with 8 to 18 carbon atoms. Regarding the glycoside residue, both monoglycosides, in which a cyclic sugar residue is glycosidically bonded to the fatty alcohol, and oligomeric glycosides with a degree of oligomerization up to, preferably, about 8 are suitable. The degree of oligomerization is a statistical average based on a homologous distribution typical for such technical products. (iii) Partial glycerides. Typical examples of suitable partial glycerides are Hydroxystearic acid monoglyceride, hydroxystearic acid diglyceride, Isostearic acid monoglyceride, isostearic acid diglyceride, oleic acid monoglyceride, Oleic acid diglyceride, ricinoleic acid moglyceride, ricinoleic acid diglyceride, linoleic acid monoglyceride, linolenic acid diglyceride, linolenic acid monoglyceride, linolenic acid diglyceride Erucic acid monoglyceride, erucic acid diglyceride, tartaric acid monoglyceride, Tartaric acid diglyceride, citric acid monoglyceride, citric acid diglyceride, Malic acid monoglyceride, malic acid diglyceride, and their technical mixtures, which may contain minor amounts of triglyceride as byproducts of the manufacturing process. Also suitable are adsorption products of 1 to 30, preferably 5 to 10 moles of ethylene oxide to the aforementioned partial glycerides. (iv) Sorbitan esters. Sorbitan monoisostearate is one of the sorbitan esters, Sorbitan sesquiisostearate, sorbitan diisostearate, sorbitan triisostearate, sorbitan monooleate, sorbitan sesquioleate, sorbitan dioleate, sorbitan trioleate, sorbitan monoerucate, Sorbitan sesquierucate, sorbitan dierucate, sorbitan trierucate, sorbitan monoricinoleate, sorbitan sesquiricinoleate, sorbitan triricinoleate, sorbitan triricinoleate, Sorbitan monohydroxystearate, sorbitan sesquihydroxystearate, sorbitan dihydroxystearate, sorbitan trihydroxystearate, sorbitan monotartrate, sorbitan sesquitrate, sorbitan ditartrate, sorbitan tritartrate, sorbitan monocitrate, sorbitan sesquicitrate, sorbitan citrate, sorbitan tricitrate, sorbitan monomaleate, sorbitan sesquimaleate, sorbitan dimaleate, sorbitan trimaleate, and their technical mixtures. Addition products from 1 to 30 are also suitable. preferably 5 to 10 mol of ethylene oxide to the aforementioned sorbitan esters. (v) Polyglycerol esters. Typical examples of suitable polyglycerol esters are polyglyceryl-2 dipolyhydroxystearate (Dehymuls® PGPH), polyglycerol-3 diisostearate (Lameform® TGI), Polyglyceryl-4 Isostearate (Isolan® Gl 34), Polyglyceryl-3 Oleate, Diisostearoyl Polyglyceryl-3 Diisostearate (Isolan® PDI), Polyglyceryl-3 Methylglucose Distearate (Tego Care® 450), Polyglyceryl-3 Beeswax (Cera Bellina®), Polyglyceryl-4 Caprate (Polyglycerol Caprate T2010 / 90), Polyglyceryl-3 Cetyl Ether (Chimexane® NL), Polyglyceryl-3 Distearate (Cremophor® GS 32) and Polyglyceryl Polyricinoleate (Admul® WOL 1403) Polyglyceryl Dimerate Isostearate and their mixtures. Examples of other suitable polyol esters are the mono-, di- and triesters of trimethylolpropane or pentaerythritol with lauric acid, coconut fatty acid, tallow fatty acid, palmitic acid, stearic acid, oleic acid, behenic acid and the like, optionally reacted with 1 to 30 mol of ethylene oxide. (vi) Anionic emulsifiers. Typical anionic emulsifiers are aliphatic fatty acids with 12 to 22 carbon atoms, such as palmitic acid, stearic acid or behenic acid, and dicarboxylic acids with 12 to 22 carbon atoms, such as azelaic acid or sebacic acid. (vii) Amphoteric and cationic emulsifiers. Furthermore, the following can act as emulsifiers: Zwitterionic surfactants are used. Zwitterionic surfactants are surface-active compounds that contain at least one quaternary ion in their molecule. They contain an ammonium group and at least one carboxylate and one sulfonate group. Particularly suitable zwitterionic surfactants are the so-called betaines, such as the N-alkyl- N,N-dimethylammonium glycinate, for example, the Cocoalkyldimethylammonium glycinate, N-acylaminopropyl-N,N-dimethylammonium glycinates, for example cocoacylaminopropyldimethylammonium glycinate, and 2-alkyl-3-carboxylmethyl-3-hydroxyethylimidazolines with 8 to 18 carbon atoms in the alkyl or acyl group, as well as the Cocoacylaminoethylhydroxyethylcarboxymethylglycinate. The fatty acid amide derivative known under the CTFA name cocamidopropyl betaine is particularly preferred. Ampholytic surfactants are also suitable emulsifiers. Ampholytic surfactants are defined as surface-active compounds that, in addition to a C8 / 18 alkyl or acyl group in the molecule, contain at least one free amino group and at least one -COOH or -SO3H group and are capable of forming internal salts. Examples of Suitable ampholytic surfactants are N-alkylglycines, N-alkylpropionic acids, N-alkylaminobutyric acids, N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidopropylglycines, N-alkyltaurines, N-alkylsarcosines, 2-alkylaminopropionic acids and alkylaminoacetic acids, each with approximately 8 to 18 carbon atoms in the alkyl group. Particularly preferred ampholytic surfactants are N-cocosalkylaminopropionate, cocosacylaminoethylaminopropionate, and C12 / 18-acylsarcosine. Finally, cationic surfactants are also suitable as emulsifiers, with those of the ester quat type, preferably methylquaternated difatty acid triethanolamine ester salts, being particularly preferred. 4. Fats and waxes Typical examples of fats are glycerides, i.e., solid or liquid plant or animal products that consist essentially of mixed glycerol esters of higher fatty acids; waxes include, among others, natural waxes such as candelilla wax, carnauba wax, Japan wax, esparto grass wax, cork wax, guaruma wax, and rice germ oil wax. Sugar cane wax, ouricury wax, montan wax, beeswax, shellac wax, spermaceti, lanolin (wool wax), preen grease, ceresin, ozokerite (earth wax), petrolatum, paraffin waxes, microwaxes; chemically modified waxes (hard waxes), such as montan ester waxes, sasol waxes, hydrogenated jojoba waxes, and synthetic waxes, such as... Polyalkylene waxes and polyethylene glycol waxes are suitable. Besides fats, fat-like substances such as lecithins and phospholipids are also suitable as additives. Lecithins are understood by experts to be those glycerophospholipids that are formed from fatty acids, glycerol, phosphoric acid, and choline through esterification. Lecithins are therefore also frequently referred to as phosphatidylcholines (PC). Examples of natural lecithins include the cephalins, which are also called phosphatidic acids and are derivatives of 1,2-diacyl-sn-glycerol-3-phosphoric acids. In contrast, phospholipids are usually understood to be mono- and preferably diesters of Phosphoric acid with glycerol (glycerol phosphates), which are generally classified as fats. Sphingosines or sphingolipids are also possible candidates. 5. Pearlescent waxes Examples of suitable pearlescent waxes include: alkylene glycol esters, especially Ethylene glycol distearate; fatty acid alkanolamides, specifically coconut fatty acid diethanolamide; Partial glycerides, especially stearic acid monoglyceride; esters of polyhydric, optionally hydroxy-substituted carboxylic acids with fatty alcohols with 6 to 22 carbon atoms, especially long-chain esters of tartaric acid; fatty substances, such as fatty alcohols, Fat ketones, fatty aldehydes, fatty ethers and fatty carbonates, which together contain at least 24 containing carbon atoms, especially lauron and distearyl ethers; fatty acids such as stearic acid, hydroxystearic acid or behenic acid, ring-opening products of olefin epoxides with 12 to 22 carbon atoms with fatty alcohols with 12 to 22 carbon atoms and / or polyols with 2 to 15 carbon atoms and 2 to 10 hydroxyl groups, as well as mixtures thereof. 6. Coolants Cooling agents are compounds that create a sensation of cold on the skin. These are generally menthol compounds, which—in addition to the basic menthol compound itself—include, for example, selected from the group formed by menthol methyl ether, menthone, and glyceryl acetal (FEMA GRAS). <1> 3807), Menthone Glyceryl Ketal (FEMA GRAS 3808), Menthyl Lactate (FEMA GRAS 3748), Menthol Ethylene Glycol Carbonate (FEMA GRAS 3805), Menthol Propylene Glycol Carbonate (FEMA GRAS 3806), Menthyl-N-ethyloxamate, Monomethyl Succinate (FEMA GRAS 3810), Monomenthyl Glutamates (FEMA GRAS 4006), Menthoxy-1,2-propanediol (FEMA GRAS 3784), Menthoxy-2-methyl-1,2-propanediol (FEMA GRAS 3849) and the menthane carboxylic acid esters and amides WS-3, WS-4, WS-5, WS-12, WS-14 and WS-30 and their mixtures. FEMA stands for "Flavor and Extracts Manufacturers Association" and GRAS is defined as "Generally Regarded As Safe". A FEMA GRAS designation means that the substance so labeled has been tested according to standard methods and is considered toxicologically safe. A first important representative of these substances is monomenthyl succinate (FEMA GRAS 3810). Both the succinate and the analogous monomenthyl glutarate (FEMA GRAS 4006) are important representatives of monomenthyl esters based on di- and Polycarboxylic acids are represented: Examples of applications of these substances can be found, for example, in publications WO 2003 043431 (Unilever) or EP 1332772 AI (IFF). The next important group of menthol compounds preferred in the sense of the invention comprises carbonate esters of menthol and polyols, such as glycols, glycerol, or carbohydrates, such as menthol ethylene glycol carbonate (FEMA GRAS 3805 = Frescolat MGC), menthol propylene glycol carbonate (FEMA GRAS 3784 = Frescolat MPC), menthol 2-methyl-1,2-propanediol carbonate (FEMA GRAS 3849), or the corresponding sugar derivatives. Also preferred are the menthol compounds menthyl lactate (FEMA GRAS 3748 = Frescolat ML) and, in particular, menthone glyceryl acetal (FEMA GRAS 3807) or menthone glyceryl ketal (FEMA GRAS 3808), which is marketed under the name Frescolat MGA. Among these substances, menthone glyceryl acetal / ketal, menthyl lactate, and menthol ethylene glycol carbonate have proven to be particularly advantageous.Menthol Propylene Glycol Carbonate, which the applicant markets under the names Frescolat<®>MGA, Frescolat<®>ML, Frecolat<®>MGC and Frescolat<®>MPC. In the 1970s, menthol compounds were first developed that have a CC bond in the 3 position, and of which there are also A number of representatives can be used. These substances are generally referred to as WS types. The basic structure is a menthol derivative in which the hydroxyl group is replaced by a carboxyl group (WS-1). All other WS types are derived from this structure, such as the preferred species WS-3, WS-4, WS-5, WS-12, WS-14, and WS-30. 7. Consistency enhancers and thickeners Consistency enhancers are primarily fatty alcohols or hydroxy fatty alcohols with 12 to 22 and preferably 16 to 18 carbon atoms, and also partial glycerides. Fatty acids or hydroxy fatty acids are considered. A combination of these substances with alkyl oligoglucosides and / or fatty acid N-methylglucamides of the same chain length and / or polyglycerol poly-12-hydroxystearate is preferred. Suitable thickening agents include, for example, Aerosil types (hydrophilic silicas), polysaccharides, in particular xanthan gum, guar gum, agar-agar, alginates and tyloses, carboxymethylcellulose and hydroxyethyl and hydroxypropylcellulose, as well as higher molecular weight polyethylene glycol mono- and diesters of fatty acids, polyacrylates (e.g., Carbopole® and Pemulen types from Goodrich; Synthalene® from Sigma; Keltrol types from Kelco; Sepigel types from Seppic; Salcare types from Allied Colloids), polyacrylamides, polymers, polyvinyl alcohol and polyvinylpyrrolidone. Bentonites, such as... have also proven particularly effective. Bentone<®>Gel VS-5PC (Rheox), which is a mixture of Cyclopentasiloxane, disteardimonium hectorite, and propylene carbonate are involved. Other possible substances include surfactants such as ethoxylated fatty acid glycerides, esters of fatty acids with polyols such as pentaerythritol or trimethylolpropane, fatty alcohol ethoxylates with a narrow homolog distribution or alkyl oligoglucosides, as well as electrolytes such as sodium chloride and ammonium chloride. 8. Superfatting agents and stabilizers Superfatting agents can include substances such as lanolin and lecithin, as well as polyethoxylated or acylated lanolin and lecithin derivatives, polyol fatty acid esters, Monoglycerides and fatty acid realkanolamides are used, the latter also serving as foam stabilizers. Metal salts of fatty acids, such as magnesium, aluminum and / or zinc stearate or ricinoleate, can be used as stabilizers. 9. Polymers Suitable cationic polymers include, for example, cationic cellulose derivatives, such as quaternized hydroxyethylcellulose, available from Amerchol under the name Polymer JR 400®, cationic starch, copolymers of diallylammonium salts and acrylamides, quaternized vinylpyrrolidone / vinylimidazole polymers, such as Luviquat® (BASF), condensation products of polyglycols and amines, quaternized Collagen polypeptides, such as lauryldimonium hydroxypropyl hydrolyzed collagen (Lamequat®L / Grünau), quaternized wheat polypeptides, polyethyleneimine, cationic silicone polymers, such as amodimethicone, copolymers of adipic acid and dimethylaminohydroxypropyldiethylenetriamine (Cartaretine® / Sandoz), copolymers of acrylic acid with dimethyl-diallylammonium chloride (Merquat® 550 / Chemviron), Polyaminopolyamides and their cross-linked water-soluble polymers, cationic Chitin derivatives such as quaternized chitosan, optionally microcrystalline dispersed, condensation products of dihaloalkyls, such as dibromobutane with Bisdialkylamines, such as bis-dimethylamino-1,3-propane, cationic guar gum, such as Jaguar® CBS, Jaguar® C-17, Jaguar® C-16 from Celanese, quaternary Ammonium salt polymers, such as Mirapol® A-15, Mirapol® AD-1, Mirapol® AZ-1 from the company Miranol. Examples of anionic, zwitterionic, amphoteric and nonionic polymers include vinyl acetate / crotonic acid copolymers, vinylpyrrolidone / vinyl acrylate copolymers, and vinyl acetate / butyl maleate / isobornyl acrylate copolymers. Methyl vinyl ether / maleic anhydride copolymers and their esters, uncrosslinked and polyol-crosslinked polyacrylic acids, acrylamidopropyltrimethylammonium chloride / acrylate copolymers, octylacrylamide / methyl methacrylate / tert. butylaminoethyl methacrylate / 2-hydroxypropyl methacrylate copolymers, polyvinylpyrrolidone, vinylpyrrolidone / vinyl acetate copolymers, vinylpyrrolidone / dimethylaminoethyl methacrylate / vinyl caprolactam terpolymers, and possibly derivatized cellulose ethers and silicones are suitable. 10. Silicone joints Suitable silicone compounds include, for example, dimethylpolysiloxanes, Methylphenylpolysiloxanes, cyclic silicones, and amino-, fatty acid-, alcohol-, polyether-, epoxy-, fluorine-, glycoside- and / or alkyl-modified silicone compounds, which are used in They can be present at room temperature in both liquid and resinous forms. Simethicones, which are mixtures of dimethicones with a The average chain length consists of 200 to 300 dimethylsiloxane units and hydrogenated silicates. 11. UV sun protection factors UV sun protection factors are, for example, organic substances (sunscreens) that are liquid or crystalline at room temperature and are capable of absorbing ultraviolet radiation and releasing the absorbed energy in the form of longer-wavelength radiation, e.g., heat. UV sun protection factors are typically present in amounts of 0.1 to 5 and preferably 0.2 to 1 by weight. UVB filters can be oil-soluble or water-soluble. Examples of oil-soluble substances include: • 3-Benzylidene camphor or 3-benzylidene norcamphor and its derivatives, e.g. 3-(4-methylbenzylidene)camphor, have been described; • 4-Aminobenzoic acid derivatives, preferably 4-(Dimethylamino)benzoic acid 2-ethylhexyl ester, 4-(Dimethylamino)benzoic acid 2-octyl ester and 4-(Dimethylamino)benzoic acid amyl ester; • Esters of cinnamic acid, preferably 4-methoxycinnamic acid 2-ethylhexyl ester, 4-methoxycinnamic acid propyl ester, 4-methoxycinnamic acid isoamyl ester, 2-cyano-3,3-phenylcinnamic acid 2-ethylhexyl ester (octocrylene); • Esters of salicylic acid, preferably salicylic acid 2-ethylhexyl ester, salicylic acid 4-isopropylbenzyl ester, salicylic acid homomoment hyal esters; • Derivatives of benzophenone, preferably 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'-methylbenzophenone, 2,2'-dihydroxy-4-methoxybenzophenone; • Esters of benzalmalonic acid, preferably 4-methoxybenzmalonic acid di-2-ethylhexyl esters; · Triazine derivatives, such as 2,4,6-trianilino-(p-carbo-2'-ethyl-l'-hexyloxy)-1,3,5-triazine and octyl triazone or dioctyl butamido triazone (Uvasorb® HEB); • Propane-1,3-diones, such as l-(4-tert-butylphenyl)-3-(4'methoxyphenyl)propan-1,3-dione; • Ketotricyclo(5.2.1.0)decane derivatives. Water-soluble substances include: • 2-Phenylbenzimidazole-5-sulfonic acid and its alkali, alkaline earth, ammonium, alkylammonium, alkanolammonium and glucammonium salts; • lH-Benzimidazole-4,6-Disulfonic Acid, 2,2'-(l,4-Phenylene)Bis-, Disodium Salt (Neo Heliopan<®>AP) · Sulfonic acid derivatives of benzophenones, preferably 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid and their salts; • Sulfonic acid derivatives of 3-benzylidene camphor, such as 4-(2-oxo-3-bornylidenemethyl)benzenesulfonic acid and 2-methyl-5-(2-oxo-3-bornylidene)sulfonic acid and their salts. Typical UV-A filters include derivatives of benzoylmethane, such as l-(4'-tert-butylphenyl)-3-(4'-methoxyphenyl)propane-l,3-dione, 4-tert-butyl-4'-methoxydibenzoylmethane (Parsol® 1789), 2-(4-diethylamino-2-hydroxybenzoyl)-benzoic acid hexyl ester (Uvinul® A Plus), l-phenyl-3-(4'-isopropylphenyl)propane-l,3-dione, and enamine compounds. UV-A and UV-B filters can, of course, also be used in Mixtures are used. Particularly favorable combinations consist of the Derivatives of benzoylmethane, e.g., 4-tert-butyl-4'-methoxydibenzoylmethane (Parsol® 1789) and 2-cyano-3,3-phenylcinnamic acid 2-ethylhexyl ester (Octocrylene) in combination with esters of cinnamic acid, preferably 4-methoxycinnamic acid 2-ethylhexyl ester and / or 4- Methoxycinnamic acid propyl ester and / or 4-methoxycinnamic acid isoamyl ester. Such combinations are advantageous with water-soluble filters such as 2-phenylbenzimidazole-5-sulfonic acid and its alkali, alkaline earth, ammonium, alkylammonium, Alkanolammonium and glucammonium salts combined. In addition to the aforementioned soluble substances, insoluble substances are also used for this purpose. Light-protective pigments, namely finely dispersed metal oxides or salts, are suitable. Examples of suitable metal oxides include zinc oxide and titanium dioxide, as well as oxides of iron, zirconium, silicon, manganese, aluminum, and cerium, and mixtures thereof. Silicates (talc), barium sulfate, or zinc stearate can be used as salts. The oxides and salts are used in pigment form for skin-conditioning and skin-protecting emulsions and decorative cosmetics. The particles should have a mean diameter of less than 100 nm, preferably between 5 and 50 nm, and particularly between 15 and 30 nm. They can be spherical, but particles with an ellipsoidal shape or a shape deviating from spherical in other ways can also be used. The pigments can also be surface-treated, i.e., hydrophilized or hydrophobized. Typical examples are coated titanium dioxides, such as...Titanium dioxide T 805 (Degussa) or Eusolex<®>T2000, Eusolex<®>T,. Eusolex<®>T-ECO, Eusolex<®>TS, Eusolex<®>T-Aqua, Eusolex<®>T-45D (all Merck), Uvinul TiO2 (BASF). Silicones, and specifically trialkoxyoctylsilanes or simethicones, are primarily used as hydrophobic coating agents. So-called micro- or nanopigments are preferred in sunscreens. Micronized zinc oxide, such as Z-COTE® or Z-COTE HPL®, is preferably used. 12. Humectants Humectants serve to further optimize the sensory properties of the composition and to regulate skin moisture. At the same time, the cold stability of the preparations according to the invention is increased, particularly in the case of emulsions. The humectants are typically present in an amount of 0.1 to 15 wt., preferably 1 to 10 wt., and particularly 5 to 10 wt.

[0080] Suitable substances according to the invention include, among others, amino acids, pyrrolidone carboxylic acid, lactic acid and their salts, lactitol, urea and urea derivatives, uric acid, and glucosamine. Creatinine, collagen breakdown products, chitosan or chitosan salts / derivatives, and especially polyols and polyol derivatives (e.g. glycerol, diglycerol, triglycerol, Ethylene glycol, propylene glycol, butylene glycol, erythritol, 1,2,6-hexanetriol, polyethylene glycols such as PEG-4, PEG-6, PEG-7, PEG-8, PEG-9, PEG-10, PEG-12, PEG-14, PEG-16, PEG-18, PEG-20), sugars and sugar derivatives (including fructose, glucose, maltose, maltitol, mannitol, inositol, sorbitol, sorbitol silanediol, sucrose, trehalose, xylose, xylitol, glucuronic acid and their salts), ethoxylated sorbitol (sorbeth-6, sorbeth-20, sorbeth-30, sorbeth-40), honey and hydrogenated honey, hydrogenated starch hydrolysates and mixtures of hydrogenated Wheat protein and PEG-20 acetate copolymer. According to the invention, glycerin, diglycerin, triglycerin and butylene glycol are preferably suitable as humectants. 13. Biogenic active ingredients and antioxidants Examples of biogenic active ingredients include tocopherol, tocopherol acetate, tocopherol palmitate, ascorbic acid, (deoxy)ribonucleic acid and their derivatives. To understand fragmentation products, β-glucans, retinol, bisabolol, allantoin, phytantriol, panthenol, AHA acids, amino acids, ceramides, pseudoceramides, essential oils, plant extracts such as Prunus extract, Bambara nut extract and vitamin complexes. Antioxidants, in particular, interrupt the photochemical reaction chain that is triggered when UV radiation penetrates the skin. Typical examples include amino acids (e.g., glycine, histidine, tyrosine, tryptophan) and their derivatives, imidazoles (e.g., urocanic acid) and their derivatives, peptides such as D,L-carnosine, D-carnosine, L-carnosine and their derivatives (e.g., anserine), carotenoids, carotenes (e.g., α-carotene, β-carotene, lycopene) and their derivatives, chlorogenic acid and its derivatives, lipoic acid and its derivatives (e.g., dihydrolipoic acid), aurothioglucose, propylthiouracil and other thiols (e.g., thioredoxin, glutathione, cysteine, cystine, cystamine and their glycosyl, N-acetyl, methyl, ethyl, propyl, amyl, butyl, and lauryl, palmitoyl, oleyl, α-Linoleyl, cholesteryl and glyceryl esters) and their salts, dilaurylthiodipropionate, distearylthiodipropionate, Thiodipropionic acid and its derivatives (esters, ethers, peptides, lipids, nucleotides, nucleosides and salts) as well as sulfoximine compounds (e.g. buthionine sulfoximines, Homocysteine ​​sulfoximine, butyronesulfones, penta-, hexa-, heptathionine sulfoximine) in very low, tolerable doses (e.g., pmol to μιηοΐ / kg), furthermore (metal) chelators (e.g., α-hydroxy fatty acids, palmitic acid, phytic acid, lactoferrin), α-hydroxy acids (e.g., Citric acid, lactic acid, malic acid), humic acid, bile acid, bile extracts, bilirubin, biliverdin, EDTA, EGTA and their derivatives, unsaturated fatty acids and their derivatives (e.g., γ-linolenic acid, linoleic acid, oleic acid), folic acid and its derivatives, ubiquinone and ubiquinol and their derivatives, vitamin C and derivatives (e.g., ascorbyl palmitate, magnesium ascorbyl phosphate, ascorbyl acetate), tocopherols and derivatives (e.g., vitamin E acetate), vitamin A and derivatives (vitamin A palmitate), coniferyl benzoate of benzoin resin, rutin acid and its derivatives, α-glycosylrutin, ferulic acid, furfurylidene glucitol, carnosine, butylhydroxytoluene, butylhydroxyanisole, nordihydroguaiac resinic acid, Nordihydroguajaretic acid, trihydroxybutyrophenone, uric acid and its derivatives, mannose and its derivatives, superoxide dismutase, zinc and its derivatives (e.g., ZnO, ZnSO4), selenium and its derivatives (e.g., selenomethionine), silibenes and their derivatives (e.g., Stilbene oxide, trans-stilbene oxide) and the derivatives suitable according to the invention (salts, esters, ethers, sugars, nucleotides, nucleosides, peptides and lipids) of these said active ingredients. 14. Hydrotropics To improve flow properties, other hydrotropes, such as ethanol, isopropyl alcohol, or polyols, can be used; these substances largely correspond to the lubricating agents described above. Polyols suitable for this purpose preferably possess 2 to 15 carbon atoms and at least two hydroxyl groups. The polyols may also contain further functional groups, particularly amino groups, or be modified with nitrogen. Typical examples are: · Glycerin; • Alkylene glycols, such as ethylene glycol, diethylene glycol, propylene glycol, butylene glycol, hexylene glycol and polyethylene glycols with an average molecular weight of 100 to 1,000 Daltons; • technical oligoglycerin mixtures with a degree of natural condensation of 1.5 to 10, such as technical diglycerin mixtures with a diglycerin content of 40 to 50 wt.- ; • Methylol compounds, such as in particular trimethylolpropane, trimethylolpropane, trimethylolbutane, pentaerythritol and dipentaerythritol; • Low alkyl glucosides, especially those with 1 to 8 carbons in the alkyl group, such as methyl and butyl glucosides; • Sugar alcohols with 5 to 12 carbon atoms, such as sorbitol or mannitol, • Sugars with 5 to 12 carbon atoms, such as glucose or sucrose; • Amino sugars, such as glutamine; • Dialcoholamines, such as diethanolamine or 2-amino-1,3-propanediol. 15. Preservatives Suitable preservatives include, for example, phenoxyethanol, formaldehyde solution, parabens, pentanediol or sorbic acid, as well as those listed under the name Surfacine<®>known silver complexes and those listed in Annex 6, Parts A and B of the further substance classes listed in the Cosmetics Regulation. 16. Perfume Oils and Aromas Perfume oils are mixtures of natural and synthetic fragrances. Natural fragrances include extracts of flowers (lily, lavender, rose, jasmine, neroli, ylang-ylang), stems and leaves (geranium, patchouli, petitgrain), fruits (anise, coriander, caraway, juniper), fruit peels (bergamot, lemon, orange), roots (mace, angelica, celery, cardamom, costus, iris, calamus), woods (pine, sandalwood, guaiac, cedarwood, rosewood), herbs and grasses (tarragon, lemongrass, sage, Thyme), needles and twigs (spruce, fir, pine, mountain pine), resins and balsams (galbanum, elemi, benzoin, myrrh, olibanum, opoponax). Animal-derived raw materials, such as civet and castoreum, are also used. Typical synthetic Fragrance compounds are products of the type of esters, ethers, aldehydes, ketones, Alcohols and hydrocarbons. Examples of ester-type fragrance compounds are benzyl acetate, phenoxyethyl isobutyrate, p-tert-butylcyclohexyl acetate, and linalyl acetate. Dimethylbenzylcarbinyl acetate, phenylethyl acetate, linalyl benzoate, benzyl formate, Ethylmethylphenylglycinate, allylcyclohexylpropionate, styralylpropionate and Benzyl salicylate. Emers include, for example, benzyl ethyl ether; aldehydes include, for example, linear alkanals with 8 to 18 carbon atoms, citral, citronellal, etc. Citronellyloxyacetaldehyde, cyclamenaldehyde, hydroxycitronellal, lilial and bourgeonal; among the ketones, e.g., the ionones, α-isomethyl ionone and methylcedryl ketone; among the alcohols, anethole, citronellol, eugenol, isoeugenol, geraniol, linalool, phenylethyl alcohol and Terpineol; the hydrocarbons mainly include terpenes and balsams. However, mixtures of different fragrance oils are preferred, as they create an appealing scent. Essential oils with lower volatility, which are usually used as aroma components, are also suitable as perfume oils, e.g., sage oil. Chamomile oil, clove oil, lemon balm oil, mint oil, cinnamon leaf oil, linden blossom oil, Juniper berry oil, vetiver oil, olibanum oil, galbanum oil, labolanum oil and lavandin oil. Preferably, bergamot oil, dihydromyrcenol, Lilial, Lyral, citronellol are used. Phenylethyl alcohol, α-hexyl cinnamaldehyde, geraniol, benzylacetone, cyclamenaldehyde, linalool, Boisambrene Forte, Ambroxan, indole, hedione, sandelice, lemon oil Mandarin oil, orange oil, allylamyl glycolate, cyclovertal, lavandin oil, clary sage oil, β-damascone, geranium oil Bourbon, cyclohexyl salicylate, Vertofix Coeur, Iso-E-Super, Fixolide NP, Evernyl, Iraldein gamma, phenylacetic acid, geranyl acetate, benzyl acetate, rose oxide, Romillat, Irotyl and Floramat, used alone or in mixtures. Examples of suitable flavorings include peppermint oil, spearmint oil, anise oil, star anise oil, caraway oil, eucalyptus oil, fennel oil, lemon oil, wintergreen oil, clove oil, menthol and the like. 17. Dyes The substances used as colorants are those suitable and approved for cosmetic purposes, such as those listed in the publication "Cosmetic Dyes" by the Dye Commission of the German Research Foundation, Verlag Chemie, Weinheim, 1984, pp. 81-106. Examples include Kochillet Red A (CI 16255). Patent Blue V (CI42051), Indigotine (CI73015), Chlorophyllin (CI75810), Quinoline Yellow (CI47005), Titanium Dioxide (CI77891), Indanthrene Blue RS (CI 69800) and Madder Lake (C.1.58000). Luminol may also be included as a luminescent dye. These dyes are typically used in concentrations of 0.001 to 0.1 wt., based on the total mixture. The total proportion of auxiliary and additive materials can range from 1 to 50, preferably 5 to 40 by weight, based on the composition. The composition can be produced by conventional cold or hot processes; preferably, the phase inversion temperature method is used. As described, the finished products can also be animal feed or animal health products. All the other products described above can be included. Embodiments or configurations, depending on the embodiment of the present invention, may be used. Animal feed, in this context, refers to any liquid or solid food intended for ingestion by the animal. This includes, for example, solutions or suspensions in water or milk, or mixtures with solid foodstuffs such as bran, flour, meat, fiber, etc. According to a preferred embodiment of the present invention, the animal feed contains so-called hydrolysates. The term hydrolysate refers to the product resulting from or arising from the hydrolysis of a substrate. The selection of a suitable substrate is determined by the desired properties of the hydrolysate at the end of the process, specifically with regard to its organoleptic properties and nutritional value. The substrate is preferably a non-dairy protein substrate, more preferably an animal protein, and even more preferably tissue from farm animals such as poultry (e.g., any species or type of bird, preferably chicken, turkey, or duck), cattle, pigs, or lambs, or from a shellfish such as shrimp, fish, or mussels. In a particularly preferred embodiment, the substrate is chicken entrails. A hydrolysate of animal protein can also be a digestive product from animal tissue. In one embodiment of the present invention, the animal proteins from which the hydrolysates are produced are obtained from viscera from suitable sources. Typically, viscera comprise the soft internal organs of the body, for example, the lungs, spleen, kidneys, brain, liver, cryopreserved defatted tissues, as well as stomachs and intestines, emptied of their contents; in particular, those organs contained within the abdominal and thoracic cavities. In addition to or alternatively to soft internal organs, viscera may include blood and / or bone. An example of the definition of viscera is given by the Association of American Feed Control Officials, Inc. (AAFCO). The AAFCO defines viscera as all organs in the three major cavities of the body (abdominal, thoracic, and pelvic), however, for fish, viscera are defined as those organs in the major cavity of the body, including the gills, heart, liver, spleen, stomach, and intestines.Similarly, AAFCO defines mammalian viscera as the organs in the large body cavity, including the esophagus, heart, liver, spleen, stomach, and intestines, but excluding the contents of the digestive tract. It defines poultry viscera as those organs in the large body cavity, including the esophagus, heart, liver, spleen, and stomach, as well as undeveloped eggs and intestines. In various embodiments, the viscera may be pretreated, for example, by stirring, homogenizing, emulsifying, and the like. Such examples are readily available to those skilled in the art. The present invention further relates to a method for producing a spinach extract, comprising the steps of: a) pretreating the spinach to obtain a mixture to be extracted. b) Performing adsorption on an adsorption resin c) Elution using a solvent with an Ex30 value of >30 or with a Solvent mixture containing at least one solvent with an Ex30 value of >30 d) Concentration Surprisingly, it has turned out that this method works for most people. Applications of the invention allow an extract with excellent properties to be obtained. In particular, the extract described above can be obtained in this way. Furthermore, in most applications of the invention, the extract exhibits one or more of the following advantages and properties: • An extract according to the invention consisting of highly diluted Solutions, emulsions or suspensions (e.g. from side streams of the (Food production). • The extract has a favorable content of β-ecdysone and polyphenols. • In contrast, the nitrate / nitrite and / or oxalate content is low. • The extract has good solubility and can therefore be used for a wide variety of applications. Applications are used • The color of the resulting extract is not particularly pronounced. The individual steps of the method are explained below, whereby the individual advantageous embodiments and details of the method can be combined with one another as desired and may, if necessary, represent individual preferred embodiments of the present invention in isolation. Step a) The term "pretreating the spinach" includes and / or means in particular that spinach is prepared in such a way that steps b) and c) can then be carried out. In a preferred embodiment of the invention, step a) includes blanching with water or aqueous solution. The term "blanching" specifically means treating the spinach with water or aqueous solution at a temperature of > 70°C, preferably > 90°C for > 10 Blanching times are preferred to be less than 10 minutes, but preferably less than 2 minutes. Blanching can be done with distilled water, but also with tap or spring water. The preferred ratio of spinach to water (in g / l) is between 50 g / l and 800 g / l. Preferably, step a) is carried out using water or an aqueous solution. Preferred additional ingredients include salts, especially table salt, as well as Antioxidants such as ascorbic acid or mixtures thereof. Alternatively or additionally, step a) can involve mixing the spinach with water or an aqueous solution and then homogenizing it. Filtration is then preferred. Step b) The term "adsorption" specifically refers to the exposure of the material to be extracted to a suitable adsorbent resin. Preferably, step b) is carried out using water or an aqueous solution, wherein the preferred ingredients are as specified above. This occurs preferably at temperatures between > 10 °C and < 60 °C, and even more preferably at temperatures between > 20 °C and < 30 °C, and most preferably at room temperature. Preferred adsorption materials are selected from the group comprising variously cross-linked polystyrenes, preferably copolymers of ethyl vinylbenzene and divinylbenzene, vinylpyrrolidone and divinylbenzene, vinylpyridine and divinylbenzene, styrene and divinylbenzene, polyaromatics, polystyrenes, poly(meth)acrylates, polypropylenes, polyesters, polytetrafluoroethylene or mixtures of these compounds. According to a preferred embodiment of the invention, the average pore size of the adsorber material is > 2 nm to < 50 nm, preferably >5 nm to <40 nm. According to a preferred embodiment of the invention, the surface area (in m²) is 2 / g) of the adsorber material of > 300 m 2 / g down to < 1200 m 2 / g, preferably > 400 m 2 / g down to < 900 m 2 / G. Particularly preferred are the substances available under the trade names LEWATIT® (e.g., LEWATIT® 1064 OC), TREVER® I SORB (e.g., TREVER® I SORB ADS 400, TREVER® I SORB ADS 700, TREVER® I SORB ADS 800), RENSA® (e.g., RENSA® PY), STRATA-X™, AMBERCHROM™ (e.g., AMBERCHROM™ CG 300m, AMBERCHROM™ CG 300c), and AMBERLITE™ (e.g., AMBERLITE™ XAD™ 7 HP). In a preferred embodiment of the invention, adsorption is carried out under flow conditions in which the material to be extracted is brought into contact with the adsorbent material. The bed volume per hour (BV / h) is preferably set to a value between >1 BV / h and <30 BV / h, preferably >15 BV / h and <20 BV / h. Step c) "Elution" specifically means that the adsorption material from step b) is exposed to a different solvent than in step b) after the adsorption process has been carried out. is so that the substances bound to the adsorption material are at least partially released (= eluted) or desorbed. The term "Ex(30) value" refers to the polarity of a solvent, and within the scope of the present invention, reference is made to the values ​​specified in Reichart; Dimroth These findings have been published in Fortschr. Chem. Forsch. 1969, 11, 1-73, Reichart Angew. Chem. 1979, 91, 119-131, and cited in March, Advanced Organic Chemistry, 4th edition, J. Wiley & Sons, 1992, Table 10.13, p. 361. When a solvent mixture is present, all solvents preferentially exhibit an Eτ30 value of >30. According to a preferred embodiment of the invention, the elution is carried out using a solvent with an Ex30 value of >45 or with a solvent mixture containing at least one solvent with an Ex30 value of >45. If a solvent mixture is present, preferably all solvents have an Eτ30 value of >45. Preferred solvents in step c) are alcohols, in particular ethanol, methanol, 1-propanol, 2-propanol, furthermore ethyl acetate, acetonitrile, DMSO and mixtures of these solvents either with each other, with other solvents or with water and / or aqueous solution. In a preferred embodiment of the invention, the adsorption is carried out by flow, in which the material to be extracted is brought into contact with the adsorption material. is passed by. The bed volume per hour (BV / h) is preferably set to a value between > 0.1 BV / h and < 10 BV / h, preferably > 2 BV / h and < 4 BV / h. Step d) Concentration Concentration can preferably be achieved by removing the solvent, for example by distillation or evaporation of the solvent. According to a preferred embodiment of the present invention, further steps may follow, including in particular and preferably freeze-drying. The present invention also relates to an extract obtainable by the method as described above. Furthermore, an extract obtained according to the method can be used in all previously described ways and in all previously described products. The aforementioned components, as well as those claimed and described in the exemplary embodiments, are not subject to any special exceptional conditions with regard to their size, shape, material selection, and technical design, so that the selection criteria known in the field of application can be applied without restriction. Further details, features and advantages of the subject matter of the invention will become apparent from the dependent claims and from the following description of the examples and figures, which are purely illustrative and not limiting. These show: Fig. 1 shows a diagram illustrating the activation of PI3K in mouse cells by treatment with several experimental solutions. Fig. 2 shows a diagram illustrating the activation of AKT in mouse cells by treatment with several experimental solutions; as well as Fig. 3 shows the increase in protein in mouse cells when treated with several Experimental solutions. Example I: Extraction from homogenized spinach The plant material (fresh spinach leaves from the local farmers' market) was prepared before extraction by cutting the individual spinach leaves into pieces approximately 1 x 1 cm in size. The entire leaf, including the rib, was used for this purpose. 50.89 g of prepared spinach leaves were weighed out and mixed with 200 mL of double-distilled water. The plant material was then homogenized using a Ultraturrax® (stage 4) was used for 2 minutes, followed by cooling to approximately 25°C. The resulting homogenate was then treated with ultrasound for 15 minutes (ultrasonic bath), during which time it was cooled to 25°C. The mixture was then centrifuged for 10 minutes at 4500 rpm before the supernatant was filtered through a pleated filter. Ice water was filtered. 150 mL of the crude extract obtained in this way was transferred to a water-rinsed Amberlite™ XAD™ 7 column and dispensed at a rate of approximately 1 drop / 5 sec. The XAD-7 material (Amberlite™ XAD™ 7HP) is a moderately polar acrylic resin with a pore size of 20-60 mesh. The column was rinsed with 200 mL of double-distilled water before elution with ethanol. Elution was performed at a slightly increased rate (approximately 3 drops / 10 sec). A clear, greenish-brown eluate was obtained. The eluate is concentrated at 40°C under reduced pressure. This is followed by gentle freeze-drying to obtain an "enriched spinach extract." The extract was then analyzed, revealing the following levels of β-ecdysone: approx. 0.0025–0.0030% Total polyphenol content: approx. 0.02% 5,3',4'-Trihydroxy-3-methoxy-6:7-methylenedioxy-flavone-4'-O-glucuronide / Spinatoside: as a total approximately 0.016% in a ratio of approximately 4:1. The ORAC value of this extract is 860 μιηοΐ TE / g. Example II: Extraction from blanched spinach The plant material (fresh spinach leaves, e.g., Pistella / Italy) is prepared before extraction. The spinach leaves were prepared accordingly by cutting them into pieces approximately 1 x 1 cm in size. The entire leaf, including the rib, was used. The starting weight was 30.42 g of leaves, which were blanched in 500 mL of boiling (approx. 95°C) double-distilled water for exactly 2 minutes. The leaves were then quickly filtered through a folded filter and the blanching water was quenched in an ice bath. 250 mL of the resulting blanching water were then poured onto a rinsed filter paper. Amberlite™ XAD™ 7 column was filled and dispensed at a rate of approximately 1 drop / 5 sec. The XAD-7 material (Amberlite™ XAD™ 7HP) is a moderately polar acrylic resin with a pore size of 20-60 mesh. The column was rinsed with 200 mL of double-distilled water before The eluate was eluted with ethanol. Concentration of the eluate took place at 40°C under reduced pressure. The extract was then analyzed and the following proportions were obtained: β-Ecdysone: 0.004% Total polyphenol content: 0.0012% 5,3^4 '-Trihydroxy-3-methoxy-6:7-methylenedioxy-flavone-4'- O-glucuronide, spinaoside: as a total of approximately 0.01% in a ratio of approximately 5:1 The ORAC value of this extract is 650 μιηοΐ TE / g. Example III: Large-scale extraction. 500 liters of spinach blanching water are transferred to a column that has been previously rinsed with water and is filled with adsorbent resin (Lewatit). This is done at a flow rate of 30 liters / hour. The column was then rinsed with 30 liters / hour of water before being eluted with 6 liters / hour of ethanol. The resulting product was then freed of a large proportion of the solvent using a rotary evaporator. The concentrate was subsequently dried further using Freeze-drying to a water content of < 5%. 58 g of product were obtained in this way. The residual moisture content was less than 4%. The extract was then analyzed and the following proportions were obtained: β-Ecdysone: 3% Total polyphenol content: 15% 5,3',4'-Trihydroxy-3-methoxy-6:7-methylenedioxy-flavone-4'-O-glucuronide: 4.3% Spinaoside: l,l% The ORAC value of this extract is 3200 μηιοΐ TE / g. Comparative example: For comparison, an ORAC value of the product available under the name "Auropure" is used. measured in spinach extract. This is approximately 300 μιηοΐ TE / g. Example IV: Effect of the extract according to the invention To investigate the therapeutic effect of the extract according to the invention, the activation of the PKB / Akt signaling pathway was examined. This signaling pathway is central to muscle activation and muscle regeneration. Cell cultures: C2C12 mouse muscle cells were obtained from Sigma-Aldrich (Taufkirchen, Germany) and stored in DMEM + 2mM Glutamine (InVitrogen / Thermo-Fisher Scientific) + 10% Fetal Bovine Serum FBS / FCS (Bio&Sell, Feucht, Germany). Protein determination: The cells to be examined were treated for 8 h with 100 μg / ml IGF-1 (Immunotools, Friesoythe, Germany (known activator for the PKB / Akt signaling pathway, positive control) and a blank sample (negative control). To determine the effect of the extract according to the invention, cells were treated with 1, 10 and 100 μg / ml extract solution using the extract according to Example III for 8 h. After treatment, the cells were treated with cold phosphate-buffered saline and then with lysis buffer (42 mM Tris-HCl, 1.3% SDS, 6.5% glycerol, 100 μM). Sodium orthovanadate and 2% phosphatase and protease inhibitors) lysed. Protein content was determined using the BCA Protein Assay Kit (Thermo Fisher Scientific, Bonn, Germany) according to the manufacturer's instructions. For Western blotting, 10–20 μg of protein from each sample was subjected to SDS-PAGE under reducing conditions. Subsequently, the proteins were transferred to a polyvinylidene fluoride membrane (PVDF membrane, Merck Millipore, Darmstadt, Germany). After blocking with 5% milk solution (BioRad, Munich, Germany) in Tris buffer solution (TBS) containing 0.1% Tween 20 (TBS-T), the membranes were incubated overnight at 4°C with the respective primary antibodies. The antibodies were diluted in TBS-T with 5% BSA. The primary antibodies used are listed in the following table: After intensive washing (3 times for 15 minutes in TBS solution containing 0.1% Tween 20), the membranes were incubated for lh with the secondary antibody, either Horseradish peroxidase-coupled anti-mouse IgG (HRP-coupled anti-mouse IgG) or horseradish peroxidase-coupled anti-rabbit IgG (HRP-coupled anti-rabbit IgG) (both Amersham / GE Healthcare, Freiburg, Germany). Densitometric analysis was performed using ImageJ software (NIH, USA), with β-actin used as a control to ensure uniform sample loading and data normalization. The results are shown in Figures 1 to 3. Figures 1 and 2 show the activation of PI3K and pAKT, respectively, while Figure 3 shows the increase in cellular protein content. It can be seen that a solution of 10 μg / ml, and even more so a solution of 100 μg / ml, are effective activators, comparable to or even surpassing IGF-1. An increased Protein concentrations in cells that exceed activation by IGF-1 are detectable even with a 1 μg / ml solution. The individual combinations of components and features from the aforementioned explanations are exemplary; the exchange and substitution of these teachings with other teachings contained in this publication and with the cited publications are also expressly considered. The person skilled in the art recognizes that variations, Modifications and other embodiments described herein may also occur without deviating from the inventive concept and scope of the invention. Accordingly, the above description is exemplary and not to be considered limiting. The word "comprise" used in the claims does not exclude other components or steps. The indefinite article "a" does not preclude the meaning of a plural. The mere fact that certain dimensions are cited in mutually different claims does not imply that a combination of these dimensions cannot be used to advantage. The scope of the invention is defined in the following claims and their equivalents. Materials and methods The β-ecdysone content can be determined by HPLC according to Serra et al., Brazilian Journal of Pharmacognosy 22(6): 1349-1354, Nov. / Dec. 2012. The polyphenol and flavonoid content can be measured according to Everette et al, J. Agric. Food Chem. 2010, 58, 8139-8144. Absorption in the UV / VIS range can be measured as described below; this is an internal method for determining color values ​​at different wavelengths. Wavelengths from different types of matrices: The relevant samples are weighed precisely and dissolved in double-distilled water. (Concentration = 10 mg / mL; equivalent to 1%), gently shaking the weighing containers. After complete dissolution of the samples (visual inspection), the samples are diluted to concentrations of 0.5% and 0.1% with double-distilled water (depending on color intensity). The samples are transferred to a clear 96-well plate, excluding the outer wells. Exactly 250 μA is added to each well. ^ The samples are pipetted, with each sample and blank being determined in triplicate (i.e., 3 wells each). All samples are placed in A duplicate determination was performed, meaning a double weighing and sample dilution was carried out. The 96-well plates are briefly agitated in the reader after being placed there, so that any air bubbles present cannot influence the determination. The measurement is performed using a Biotek Synergy 4 series multi-mode microplate reader, with Gen5 software used for control. Blank values ​​and the samples are measured for color determination at the following wavelengths: 440 nm, 662 nm, 580 nm and 507 nm. The blank values ​​(in this case double-distilled) Water) are subtracted from the sample values. The temperature during the The described experiments were conducted at 23°C, which was kept constant by the device. The evaluation was performed using the software employed. The antioxidant effect (ORAC value) can be measured according to Prior et al, J. Agric. Food Chem. 2005, 4290-4302.

Claims

Patent claims Spinach extract containing >0.002 to <15% β-ecdysone and >0.01% to <50% polyphenols, each as mass fraction in the dry product. Extract according to claim 1, wherein the polyphenols contain flavonoids. Extract according to claim 1 or 2, wherein the extract contains at least one flavonoid selected from the group comprising: 5,3',4'-Trihydroxy-3-methoxy-6,7-methylenedioxyflavone 4'-glucuronide with the following structure: Jaceidin 4'-glucuronide = (3S,6S)-6-[4-(5,7-dihydroxy-3,6-dimethoxy-4-oxochromen-2-yl)-2-methoxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid with the following structure: Spinacetin 3-gentiobioside = 5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-6-methoxy-3-[(2R,5S)-3,4,5-trihydroxy-6-[[(2R,4S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl] oxychromene-4-οη with the following structure: Isorhamnetin 3-sophoroside-7-glucoside = 3-[(2S,5S)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxane-2- yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-7-[(2S,4S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one with the following structure: Sinatoside = f3,4',5,7-Tetrahydroxy-3',6-dimethoxyflavone with the following structure Extract according to any one of claims 1 to 3, wherein the extract contains spinatoside to 5,3',4'- trihydroxy-3-methoxy-6:7-methylenedioxy-flavone-4'- O-glucuronide in a ratio between >1:0.1 and <1:

20. A method for producing a spinach extract, comprising the steps of: a) pretreating the spinach to obtain a mixture to be extracted; b) carrying out adsorption on an adsorbent resin. c) Elution using a solvent with an Ex30 value of >30 or a solvent mixture containing at least one solvent with an Ex30 value of >30 6. The method of claim 5, wherein step a) comprises blanching the spinach.

7. The method of claim 5 or 6, wherein step c) is carried out using a solvent having an Ex30 value >45 or a solvent mixture containing at least one solvent having an Ex30 value >45. 8 Spinach extract, producible by a process according to claims 5 to 7.

9. Flavoring mixture comprising a spinach extract according to any one of claims 1 to 4 or 8.

10. Food and / or food supplement comprising a spinach extract according to any one of claims 1 to 4 or 8 or a flavoring mixture according to claim 9.

11. Animal feed comprising a spinach extract according to any one of claims 1 to 4 or 8, or a flavoring mixture according to claim 9.

12. Pharmaceutical comprising a spinach extract according to claims 1 to 4.

13. Pharmaceutical for the treatment of muscle atrophy, muscle hypotonia, and / or Sarcopenia comprising a spinach extract according to claims 1 to 4.

14. Cosmetic composition comprising a spinach extract according to any one of claims 1 to 4.